UCB's Global Corporate Website
Welcome to UCB in the United States

Health Systems

Immune-Mediated Inflammatory Diseases (IMIDs) present an increasingly significant burden to patients, providers, and payors.

As Health Systems look for new ways to elevate care for patients, UCB strives to improve the patient’s clinical journey and works to support the evolution to high-quality, value-based care.

Resources and Quality Measures

Why You Should Identify axSpA Patients Early

Minimize the diagnostic delay for patients at risk for axSpA


axSpA ID EHR Instructions

EHR instructions that provide clinical criteria for identifying patients with potential underlying axSpA


Quality Measures in Rheumatology and Dermatology

Explore the impact of quality care measures for patients with immune-mediated inflammatory diseases (IMIDs)

Psoriasis Patient Journey Care Gap Map

Take a closer look at the end-to-end patient experience

Contact us for more information

The Evolving Role of Digital Health: Perspectives from Immunology Health Leaders

Explore the advances in digital health and how they can be leveraged to improve both patient outcomes and experience.

A Value-Based Collaborative Care Model by Payers, Providers, and Pharma

Learn about building a model that prioritizes a holistic view of the patient, promotes communication among all those caring for the patient, and proactively confronts common barriers in the way of best practice protocols.

Contact Your Ecosystems Partner for More Information

Wellness4U Peer-to-Peer Programs

Explore our wide range of continuing education programs